
Every aspect of our mammography teleradiology service is built around federal compliance requirements, clinical accuracy, and the specific needs of breast imaging programs.
All mammography reads are performed by radiologists who meet or exceed MQSA (Mammography Quality Standards Act) physician requirements — including minimum annual read volumes and continuing medical education in mammography. Compliance documentation is available on request.
We interpret both conventional 2D digital mammography and 3D digital breast tomosynthesis (DBT) — including combo mode studies (2D + 3D acquired together). Our readers are experienced on GE, Hologic, Siemens, and Fujifilm mammography systems.
Screening mammography reads, diagnostic mammography workups, and additional views (spot compression, magnification, rolled views) are all covered. Diagnostic reads include clinical correlation with patient history provided by your center.
Every mammography report uses ACR BI-RADS 5th Edition structured reporting — including BI-RADS assessment category, composition category, findings description, and recommendation. Reports are formatted to your PACS or RIS requirements.
Key metrics across breast imaging center partners

The Mammography Quality Standards Act (MQSA) establishes specific requirements for radiologists who interpret mammography studies — requirements that go beyond standard board certification. Any teleradiology provider offering mammography reads must meet these federal standards, and your facility remains responsible for ensuring the interpreting physicians comply.
At Natoe AI, all mammography reads are performed by physicians who meet MQSA's initial qualification and continuing experience requirements. This includes minimum annual interpretive volumes (960 mammographic examinations per 24 months) and ongoing mammography-specific CME. We maintain MQSA compliance documentation for each reading physician and provide it to client facilities on request.
MQSA also requires that mammography reports be issued directly in the patient's name and that results be communicated to the patient within 30 days. Our reporting workflow supports both requirements — reports are structured per ACR BI-RADS guidelines and formatted for direct patient communication when needed.